Antigenic targets and pathogenicity of anti–aortic endothelial cell antibodies in Takayasu arteritis
Open Access
- 27 June 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (7) , 2326-2333
Abstract
Objective: Anti–endothelial cell antibodies are considered to have an important role in the pathogenesis of Takayasu arteritis (TA). Previously, these antibodies were detected using human umbilical vein endothelial cells, which do not completely represent the antigenicity/functions of aortic endothelial cells, the specific targets in TA. To delineate the precise role of antigenic targets, we investigated such targets as well as the pathogenic mechanism of antibodies directed against aortic endothelial cells (AAECAs) in TA.Methods: AAECAs were detected using a cellular enzyme‐linked immunosorbent assay (ELISA), and their antigenic targets were detected by immunoblotting. AAECA‐mediated induction of endothelial adhesion molecule expression and cytokine production was studied by ELISA, and apoptosis was studied using the TUNEL method.Results: AAECAs were detected in 86% of patients with TA and in 9% of controls. Sera obtained from AAECA‐positive patients with TA recognized a total of 9 antigens ranging in size from 18 kd to 200 kd, of which the 60–65‐kd triplet was recognized most often. The aortic endothelial cell reactivity of Hsp60‐absorbed sera was reduced by ∼50% as compared with that of unabsorbed sera (mean ± SD 0.488 ± 0.08 versus 0.838 ± 0.116). Sera from AAECA‐positive patients with TA, compared with sera from AAECA‐negative patients with TA and that from controls, induced increased expression of E‐selectin (mean ± SD 0.833 ± 0.063 versus 0.217 ± 0.081 and 0.221 ± 0.101 optical density [OD] units, respectively) and vascular cell adhesion molecule 1 (0.620 ± 0.144 versus 0.165 ± 0.005 and 0.177 ± 0.055 OD units, respectively) and increased production of interleukin‐4 (IL‐4) (6.8 ± 2.4 versus 1.2 ± 1.6 and 1.3 ± 2.5 pg/ml, respectively), IL‐6 (24.3 ± 2.4 versus 4.5 ± 6.7 and 5.9 ± 5.1 pg/ml, respectively), and IL‐8 (36.8 ± 10.3 versus 10.1 ± 6.7 and 7.8 ± 2.1 pg/ml, respectively). Sera from AAECA‐positive patients with TA induced 29 ± 6% (median ± SEM) apoptosis of aortic endothelial cells.Conclusion: Our data show that the AAECAs that are present in patients with TA are directed mainly against 60–65‐kd antigen(s) and may cause vascular dysfunction by inducing expression of endothelial adhesion molecules, cytokine production, and apoptosis.Keywords
This publication has 30 references indexed in Scilit:
- Induction of endothelial cell apoptosis by the binding of anti–endothelial cell antibodies to Hsp60 in vasculitis‐associated systemic autoimmune diseasesArthritis & Rheumatism, 2005
- Autoantibodies to Vascular Smooth Muscle Are Pathogenic for VasculitisThe American Journal of Pathology, 2005
- Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodiesKidney International, 2004
- Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implicationsArthritis & Rheumatism, 2001
- Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodiesArthritis & Rheumatism, 1998
- The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis.Journal of Clinical Investigation, 1998
- Anti‐endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretionArthritis & Rheumatism, 1996
- Anti‐CD36 antibodies in thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 1994
- Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis.Journal of Clinical Investigation, 1994
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989